New York, NY, United States of America

Megan Shaw

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
3 patents (USPTO):Explore Patents

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. For information about Megan Shaw, here is the article structure you requested:

Title: The Inventor Extraordinaire: Megan Shaw

Introduction:

Megan Shaw, a trailblazing inventor based in New York, NY, has made significant contributions to the field of antiviral research. With a total of 3 patents under her belt, Shaw's innovative work in inhibiting human host factors necessary for influenza virus replication has garnered attention and acclaim.

Latest Patents:

1. "Compositions and methods for inhibiting human host factors required for influenza virus replication": Shaw's groundbreaking patent focuses on the modulation of host cell factors crucial for the replication of influenza virus. Her work involves developing compounds, including nucleic acid compounds and small molecules, that target these host cell factors, offering new possibilities for antiviral treatments.

2. "Antiviral compounds and uses thereof": Shaw's second patent showcases her expertise in designing compounds that serve as potent antiviral agents. This patent highlights methods for inhibiting viral replication, preventing symptoms of viral infections, and managing viral infections effectively.

Career Highlights:

Shaw's illustrious career includes significant roles at prestigious institutions such as the Icahn School of Medicine at Mount Sinai and The Salk Institute for Biological Studies. Her tenure at these renowned establishments underscores her expertise and dedication to advancing antiviral research.

Collaborations:

Throughout her career, Shaw has collaborated closely with esteemed professionals in the field, including Peter M. Palese and Adolfo Garcia-Sastre. These collaborations have been instrumental in shaping Shaw's innovative approaches to combatting viral infections and enhancing antiviral therapies.

Conclusion:

In conclusion, Megan Shaw stands out as a pioneering inventor in the realm of antiviral research. Her patents, career achievements, and collaborative efforts underscore her dedication to advancing scientific knowledge and developing novel solutions for combating viral infections. Shaw's contributions continue to inspire and drive innovation in the field of antiviral research.

Please let me know if you need more information or if there is anything else I can assist you with.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…